Sep 1, 2022 · 30m · saastr
The 7 Tips to Setting Yourself Apart During the Venture and Growth Stages with Atomico
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Irina and Hillary from venture capital firm Atomico provide a comprehensive guide on how investor evaluation criteria evolve from early-stage venture rounds to growth stages across product, market, team, and narrative.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
Jason as informed peer 0.0 Guest teaching 0.0 Guest disagreement 0.0 Jason pushing back 0.0
speaking balance: gold is Jason, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 19:18 Audience interjection on narrative value
An audience member calls out asking 'Why?', prompting Irina to immediately justify why narrative is the single most critical cross-stage pillar.
Hardest push from Jason ▶ 21:53 Hillary rejects strict ARR threshold framingHillary pushes back against the premise that specific ARR numbers are required at each stage, clarifying that metrics fluctuate and early validation takes many non-revenue forms.
Biggest teaching moment ▶ 22:31 Irina breaks down pre-revenue Series A investingIrina educates the audience by explaining how she has led Series A rounds with zero revenue when community engagement and daily active usage were exceptionally strong.
Jason holds their own ▶ 27:28 Irina demonstrates cap table pitfalls and dilution red flagsIrina showcases her deep early-stage venture experience by pinpointing why university spin-outs with 30% academic IP overhang create broken, uninvestable cap tables.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Jason as informed peer | Guest teaching | Guest disagreement | Jason pushing back | Why |
|---|---|---|---|---|---|---|
| Assessing Market Opportunity and Expansion Vectors | 0 | 0 | 0 | 0 | Irina and Hillary deliver a joint presentation breaking down how early-stage versus growth-stage venture capitalists evaluate market size, theoretical TAM, and expansion vectors. Because this is a prepared conference workshop with no active host interaction, all engagement metrics remain at zero. | |
| Developing Product Vision and Validating Secret Sauce | 0 | 0 | 0 | 0 | The speakers discuss defining a product's secret sauce at early stages and proving usage, engagement, and willingness to pay by growth stage. The dynamic is structured and collaborative as they alternate perspectives. | |
| Maturing Go-to-Market Strategies and Sales Efficiency | 0 | 0 | 0 | 0 | Haivas and Ball outline go-to-market strategies, covering bottom-up community adoption, top-down enterprise motions, and growth-stage sales efficiency metrics like payback periods and repeatable playbooks. | |
| Establishing and Validating Sustainable Competitive Advantage | 0 | 0 | 0 | 0 | Irina and Hillary walk through competitive moats, contrasting early-stage positioning like IP or category creation with growth-stage quantitative and qualitative customer validation. | |
| Founder-Market Fit, Team Building, and Culture | 0 | 0 | 0 | 0 | The presenters discuss founder-market fit, talent attraction, organizational scaling, and the criticality of establishing deliberate company culture and diversity early. | |
| The Power of Narrative and Session Conclusion | 0 | 0 | 0 | 0 | Irina wraps up the main presentation by stressing the unifying power of an enduring narrative, briefly answering an audience prompt about narrative importance before opening the floor to audience Q&A. | |
| Q&A: Stage-Specific ARR Benchmarks and Alternative Metrics | 0 | 0 | 0 | 0 | An audience member asks about expected ARR benchmarks per funding stage. Hillary and Irina clarify that strict ARR thresholds do not exist at Atomico, citing non-revenue usage and community metrics that justify pre-revenue Series A rounds. | |
| Q&A: Key Drivers for Passing on Investment Opportunities | 0 | 0 | 0 | 0 | Founder Jordi asks what causes Atomico to pass on deals. Irina and Hillary explain that outcome scale limitations, missing founder complement, and vision misalignment are the primary drivers. | |
| Q&A: Cap Table Health, Dilution, and Founder Equity | 0 | 0 | 0 | 0 | Audience members ask about cap table ownership thresholds and exit alignment. Irina details warning signs like heavy university IP dilution and explains Atomico's founder-friendly approach to acquisition offers. |
Statements from this episode (11)
Ball: Startup Narrative Remains Essential From Seed Stage Through Growth Rounds
“There is one row on this table where that need for validation is there even from the earliest stages from the seed. Which is this idea around the narrative. And this becomes really important because of this dynamic at the early stages where a lot of these area…”
Haivas: Required Startup Market Size Depends on VC Fund Size
“There isn't a minimum market size. We often get asked, like, you know, what do you want to see? And the reality is different funds will Expect different market sizes based on their own fund size, their own strategies, but I, one exercise that's always good to …”
Haivas: Dev tool startups must build community love before top-down enterprise sales
“If you're building a dev tool company, your go to market is likely going to be different than if you're building an enterprise automation company, which means you're likely to have to think about how to create those user attraction and community love before yo…”
Ball: Growth investors run broad customer surveys to rank products against rivals
“Many growth investors will also have a quantitative approach as well to validating this competitive advantage, which will be running wide market surveys of these customer groups to also understand how your product ranks relative to potentially competing soluti…”
Haivas: Culture and Diversity Are Harder to Fix at 100 Employees
“Culture needs to be a deliberate strategy and a consistent effort over time, and that you cannot course correct it, or that it's much harder to course correct later on. In particular, key elements of culture, such as diversity and inclusion, they become much h…”
Haivas: Pitch decks do not need explicit market sizing calculations
“The most important thing is that you show the definition of what is the market, and what is the TAM, and what is the SAM, and then show the numbers, and I don't necessarily think that the decks should show the calculations.”
Ball: Atomico does not require set ARR benchmarks across venture stages
“For us we don't have a set expected ARR at each of these stages, and I think we see that it varies. Sometimes we see series A or series B companies that might be still pre-launch and so that's why we'll look at some of these other ways to validate things like …”
Haivas: Atomico Has Backed Pre-Revenue Series A Startups for 18 Months
“I've certainly invested in companies where at Series A there was no revenue and there was no plan to have a revenue for the next A year to 18 months because the focus was on community and usage.”
Haivas: Atomico Passes on $800M Startup Exits Due to Fund Size
“We are a pretty large fund, and so we will look for really outsized outcomes, multi-billion dollar type of outcomes, and sometimes you can, we can see, probably that's the most common one. Like, for me, sometimes I see this is gonna be a great business, but I …”
Haivas: 30% University Equity Stakes Make Spin-Out Cap Tables Uninvestable
“What we have had challenges with in the past is, for instance, university spin-outs where you have like a 30% Owned by a university because you have taken the IP from there. I think those are very difficult cap tables for us to get into.”